The present invention relates to a food composition for preventing obesity, a pharmaceutical composition for treating obesity, and an animal medicine for treating obesity, containing gingerenone A as an active ingredient, wherein gingerenone A is contained as an active ingredient for inhibiting: fat accumulation the expression of C/EBPα and PPARγ which are important transcription factors expressed during differentiation into fat cells and the expression of FAS, and thus the present invention shows excellent effects for preventing or treating obesity.La présente invention concerne une composition alimentaire destinée à prévenir lobésité, une composition pharmaceutique destinée à traiter lobésité, et un médicament vétérinaire destiné à traiter lobésité, contenant du gingerenone A en tant que principe actif, le gingerenone A étant contenu en tant que principe actif afin dinhiber : laccumulation de graisse lexpression du C/EBPα et du PPARγ qui sont dimportants facteurs de transcription exprimés dans le cas de la différenciation en cellules adipeuses et lexpression du FAS. La présente invention présente ainsi dexcellents effets de prévention ou de traitement de lobésité.본 발명은 진저레논 에이를 유효성분으로 함유하는 것을 특징으로 하는 비만 예방용 식품 조성물, 비만 치료용 약학 조성물 및 비만 치료용 동물 의약품에 관한 것으로, 지방 축적 억제 효과, 지방 세포로의 분화 시 발현되는 중요한 전사인자인 C/EBPα, PPARγ의 발현 저해 효과 및 FAS 발현 저해 효과를 발휘하는 진저레논 에이를 유효성분으로 함유하기 때문에 우수한 비만 예방 또는 치료 효과를 발휘한다.
